Stock Movers Fresnillo Rises, Barclays Falls, Abivax Surges
Jan 12, 2026
Louise Moon, Breaking News editor at Bloomberg, dives into the booming market dynamics surrounding gold and silver, driving miners like Fresnillo to new heights. She discusses the fallout from Donald Trump's controversial remarks affecting Barclays, pushing its shares down significantly. Additionally, speculation around a potential takeover of French biotech Abivax sparks a remarkable 31% surge, alongside chatter of a €15 billion bid from Eli Lilly. This lively conversation covers critical insights into the financial landscape.
AI Snips
Chapters
Transcript
Episode notes
Precious Metals Rally Fueled By Risk And Fed Concerns
- Gold and silver hitting records drove Johannesburg mining stocks and miners like Fresnillo higher.
- Louise Moon links the rally to DOJ threats toward the Fed and geopolitical risk increasing demand for safe assets.
Political Pressure Hits Banks
- Barclays shares plunged after President Trump demanded credit-card rates be capped at 10% for a year and set a January 20 deadline.
- Louise Moon notes the demand lacks legislative backing but still pressures banks due to political risk and Barclays' US credit-card exposure.
Abivax Soars On Takeover And Trial Hopes
- Abivax jumped as much as 31% on takeover speculation, driven by expected clinical trial results for an IBD drug.
- French reports claim Eli Lilly could bid €15 billion, though the company hasn't confirmed the speculation.